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Abstract 
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The exact antioxidant status in breast cancer patient is still not clear. So present study was 
focused on enzymic antioxidants such as Superoxide dismutase, Catalase, Glutathione-S-
transferase, Glutathione peroxidase and Glutathione reductase in the serum of 25 
histopathologically proven breast cancer patients. When the data were analyzed with age 
matched control the antioxidant  levels were found to decrease indicating enhanced  free 
radical activity in breast cancer patients while the antioxidant defense mechanism is 
weakened. However further elaborate clinical studies are required to evaluate the role of 
such antioxidant enzymes in breast cancer management. 
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Introduction 
Breast caner is one of the most common malignant 
tumors in our country. Recently, patients suffering from it and 
dying of it are increased. Though breast cancer could be found 
early, some patients still died of metastasis and recurrence [1]. 
Alteration in the oxidant -antioxidant profile is known to occur in 
cancer [2]. Oxidative stress is due to a disturbance in the 
balance between the production of ROS and the efficiency of 
the antioxidant defense. In other words, oxidative stress results 
if excessive production of ROS overwhelms the antioxidant 
defense system or when there is a significant decrease or lack 
of antioxidant defense [3]. Experimental evidence revels that 
ROS (reactive oxygen species) are involved in initiation and 
promotion of carcinogenesis, where inactivation or loss of 
certain tumor suppressor genes is occurred [4]. Free radicals 
are formed in both physiological and pathological conditions in 
mammalian tissues.  Free radicals are capable of altering all 
major classes of biomolecules, such as lipid, nucleic acid and 
protein, with changes in their structure and function [5]. Prime 
targets of free radicals are poly unsaturated fatty acid in cell 
membranes and their interaction results in lipid peroxidation. 
The levels of free radical molecules are controlled by various 
cellular defense mechanisms, consisting of enzymatic 
(Catalase, Glutathione peroxidase, Superoxide dismutase) and 
non-enzymatic (vit.E,vit.C and Glutathione) components [6].  
We therefore examined the levels of Superoxide dis mutase, 
Catalase, Glutathione-S-transferase, Glutathione peroxidase 
and Glutathione reductase in breast cancer patients. 
Materials and Methods 
Blood samples were collected from Aringar Anna Cancer 
Institute, Kancheepuram from 25 clinically and 
histopathologically proven breast cancer patients and 
compared with age matched control. The patients were not 
using hormones, oral contraceptives and were non-smokers. 
None of them had secondary disorder. Informed consent was 
obtained from all the participants. The human ethics committee 
of office of the Director, Govt. Arignar Anna Memorial cancer 
Hospital, Regional Cancer Center, Karapettai, Kancheepuram 
vide Ref.No.262/E1/08 has approved the study. Controls 
consisted of members of the public with no previous history of 
breast cancer and other cancer related diseases. Blood 
samples were collected, centrifuged for 15 minutes at 3000rpm 
and the serum was separated and stored at 4˚C for analysis. 
Superoxide dis mutase was assayed by following the inhibition 
of autooxidation of epinephrine spectrophotometrically at 480 
nm by Misra Friedovich method. Catalase activity was 
estimated by measurement of chromic acid in serum at 620 nm 
by Sinha method. Glutathione peroxidase activity was 
estimated according to the method of Rotruck et al. with 
modifications. A known amount of enzyme preparation was 
allowed to react with H2O2 in the presence of reduced 
glutathione. after specified time period, the remaining 
glutathione content was measured as described by Anderson. 
The activity of Glutathione-S-transferase was assayed by the 
method of Habig et al. by following the increase in absorbance 
at 340 nm using 1-Chloro-2,4-dinitrobenzene (CDNB) as the 
substrate. The activity of Glutathione reductase was estimated 
by Pinto Barley method. The data for biochemical analysis are 
expressed as mean and standard deviation (SD). The 
statistical comparisons were performed by one way ANOVA. 
Results and Discussion 
The mean body weight of breast cancer patient was 
61(range 50 - 74) which alters slightly during the study. Values 
are mean standard deviation of 50 breast cancer patients and 
controls are indicated in Table 1. The mean and standard 
deviation of Antioxidant status in breast cancer patients in 
comparison with age matched control are indicated in Table 2. 
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Table 1: Mean body weight of Breast cancer patients compared to control. 
 
 
 
 
 
Table 2: Serum Antioxidant level in Breast cancer Patients compared to control.  
Parameters  Control Breast Cancer Patient 
SOD(Unit/mL) 3.2 ± 0.51 1.7 ± 0.16** 
CAT(Unit/mL) 5.2 ± 0.94 2.8 ± 0.85** 
GST(µ mol/ min) 1.65 ± 0.02 1.12 ± 0.05** 
GPx(µ mol/ min) 10 ± 0.5 7.3 ± 2.5** 
GRx(µ mol/ min) 4.5 ± 0.05 1.0 ± 0.05** 
 **p< 0.001 as compared to respective control 
 
The reactive oxygen species (ROS) play an important role 
in tumor initiation, and that ROS levels, in a healthy organism, 
are controlled by endogenous mechanisms including 
glutathione and enzymes like catalase or superoxide 
dismutase [7]. Elevated ROS levels can initiate DNA damage, 
and might ultimately lead to carcinogenesis [8]. Compounds 
capable of either scavenging free radicals or suppression of 
superoxide generation and antioxidant compounds show 
cancer chemopreventive effects  [9]. Oxidative stress caused 
by increased free radical generation and/or 
decreasedantioxidant level in the target cells and tissues has 
been suggested to play an important role in carcinogenesis 
[10-12]. It has been hypothesised that the production of ROS 
combined to a decreased antioxidant enzyme level may be 
characteristic of tumour cells [13,14]. 
 SOD and Catalase are considered as primary antioxidant 
enzymes,since they are involve in direct elimination reactive 
oxygen metabolites.They also act as anti carcinogensand 
inhibitors at initiation and promotion /transformation stage in 
carcinogenesis.Mutation caused bypotassium superoxide in 
mammalian cellsis bloked by SOD.Catalase also prevents 
chromosomal aberration by hypoxanthine/xanthine Oxidase in 
Chinese hamster cells [15]. In the present study the level of 
SOD and CAT were found to be lower in breast cancer patients 
when compared to control which is similar to the study of Sinha 
et al [16]. Fridovich and Tayarani [17-19] have demonstrated in 
their respective study that the reduction in SOD activities 
increases the toxic effect ofO2 and might lead to cellular 
damage.    
The second line of defense against ROS is provided by 
Glutathione enzymes. Glutathione (GSH) is the most abundant 
thiol in cells that can directly scavenge free radical or act as 
substrate for Glutathione peroxidase (GPx) or Glutathione-S-
transferase (GST) during detoxification of H2O2 and 
electrophillic compounds. Glutathione peroxidase reduces 
H2O2 and organic peroxides (ROO) while oxidizing GSH. 
Oxidized Glutathione (GSSG) is reduced back to GSH by 
Glutathione reductase (GR) in the presence of f NADPH. GSH 
in conjugation with GPx, plays a central role in defense against 
free radicals, peroxides and a wide range of xenobiotics and 
carcinogens [20]. According to Vanu Ramkumar Ramprasad, 
Cancer bearing animals showed a significant decrease  in 
Glutathione enzymes when compared to control animals  
which supports the present study that these enzymes were 
found to decrease in breast cancer patients. From the results 
of the present study, we suggest that increased lipid 
peroxidation and decrease in antioxidant defense is associated 
with the development of breast  cancer may offer a selective 
growth advantage to tumour cells over their surrounding 
normal counter parts. However, further clinical studies are 
required before a definitive conclusion to be drawn. 
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